Mosley Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$194K Buy
3,371
+3,200
+1,871% +$184K 0.06% 157
2026
Q1
$7.72K Buy
+171
New +$9.97K ﹤0.01% 319
2024
Q3
Sell
-6,937
Closed -$288K 116
2024
Q2
$288K Buy
6,937
+730
+12% +$32.7K 0.25% 84
2024
Q1
$337K Sell
6,207
-72
-1% -$3.67K 0.32% 73
2023
Q4
$322K Buy
+6,279
New +$330K 0.32% 69

Other funds holding BMY

Mosley Wealth Management's BMY Position: Q2 2026 in Review

Mosley Wealth Management increased its Bristol-Myers Squibb (BMY) stake by 1,871% in Q2 2026, buying an estimated $184K and bringing the position to 3,371 shares worth $194K. The position accounts for 0.06% of the portfolio, ranked #157.

Mosley Wealth Management first reported a position in BMY in Q4 2023 and has held it in 5 quarters since. The position peaked at $337K in Q1 2024. 1,584 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

  • Mosley Wealth Management held 3,371 shares of Bristol-Myers Squibb worth $194K as of Q2 2026.
  • Mosley Wealth Management bought 3,200 Bristol-Myers Squibb shares in Q2 2026, an estimated $184K.
  • Bristol-Myers Squibb made up 0.06% of Mosley Wealth Management's portfolio in Q2 2026, its #157 holding.
  • Mosley Wealth Management first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 5 quarters since.
  • Mosley Wealth Management's Bristol-Myers Squibb position peaked at $337K in Q1 2024.
  • 1,584 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Mosley Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.